What is BofA Securities's price target for CLBT?

BofA Securities's latest stated price target for Cellebrite DI Ltd. (CLBT) is $12, from its action on Feb 16, 2024.

What is BofA Securities's rating on CLBT?

BofA Securities rates CLBT Buy, a bullish rating, as of Feb 16, 2024.

When did BofA Securities last change its view on CLBT?

On Feb 16, 2024, BofA Securities upgrades to Buy from Neutral, price target $9 to $12.

BofA Securities CLBT price target and rating history

BofA Securities rates Cellebrite DI Ltd. (CLBT) Buy with a $12 price target, as of its latest action on Feb 16, 2024. It has published 3 rating actions on CLBT since December 2021, including 1 upgrade and 1 downgrade.

Current rating: Buy
Price target: $12
Median target, all firms: Too few
Actions on CLBT: 3

BofA Securities price target on CLBT

BofA Securities price target on CLBT, each point a stated target, December 2021 to February 2024.

Every BofA Securities rating on CLBT

Feb 16, 2024
UpgradeBofA Securities upgrades to Buy from Neutral, price target $9 to $12
Aug 12, 2022
DowngradeBofA Securities downgrades to Neutral from Buy, price target $6.50 to $6
Dec 2, 2021
InitiateBofA Securities starts coverage at Buy, price target $11

Questions about BofA Securities and CLBT

What is BofA Securities's price target for CLBT?: BofA Securities's latest stated price target for Cellebrite DI Ltd. (CLBT) is $12, from its action on Feb 16, 2024.
What is BofA Securities's rating on CLBT?: BofA Securities rates CLBT Buy, a bullish rating, as of Feb 16, 2024.
When did BofA Securities last change its view on CLBT?: On Feb 16, 2024, BofA Securities upgrades to Buy from Neutral, price target $9 to $12.

More CLBT rating histories

All BofA Securities ratings CLBT news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.